We were excited to see a lot of CSANZ presenters at this year’s ESC Cardiology Conference held over the past 3 days 27 – 30 August 2021. Also featured – in the Late Breaking Trials was Monash University and Victorian Heart Institute’s Director, (and CSANZ President elect) Prof Stephen Nicholls presenting the novel findings of the HUYGENS Study.
This research shows that treatment with high dose statins and Evolocumab stabilises vulnerable plaque in one year.
Prof Nicholls says “We CAN stabilise plaques after an ACS”